Increase in total research and development expenses
First written in FY2019-Q2. . Latest entry: FY2026-H1.
96 other companies' latest entry also says "Other".
- FY2026-H1Increase in R&D ExpensesAnnual report
「Total R&D expenses for the current interim consolidated period were ¥46 million.」
Total R&D expenses increased from ¥13 million in the same period of the previous year to ¥46 million. Increased R&D expenses, among other factors, were cited as a reason for the decline in segment profit in the financial solutions business. - FY2025Decrease in R&D expensesAnnual report
「The company mainly developed systems to address exchange-related regulatory changes and system upgrades, secret-sharing technology for data protection, encryption and decryption applications, and a cryptocurrency trading platform, among other projects. For the current fiscal year, the amount invested in R&D was ¥51 million.」
The financial solutions business continued R&D on exchange system upgrades, secret sharing, encryption and decryption, and cryptocurrency trading platforms, among other areas, but R&D expenses decreased from approximately ¥74 million in the previous fiscal year to ¥51 million. - FY2025-H1Decrease in R&D expensesAnnual report
「Total R&D expenses for the current interim consolidated period were ¥13 million.」
R&D expenses for the current interim period were ¥13 million, down from ¥29 million in the same period of the previous year. - FY2024Increase in R&D ExpensesAnnual report
「For the current fiscal year, the amount invested in R&D was ¥73 million.」
R&D expenses increased from ¥61.6 million in the previous fiscal year to ¥73.9 million. The funds were invested in exchange-related regulatory changes and system upgrades, secret sharing, and encryption and decryption applications, among other areas. - FY2024-Q2Increase in R&D ExpensesAnnual report
「Total R&D expenses for the first six months of the current fiscal year were ¥29 million.」
Total R&D expenses increased from ¥8 million in the same period of the previous year to ¥29 million. - FY2024-Q1Increase in R&D ExpensesAnnual report
「Total R&D expenses for the current consolidated cumulative period were ¥16 million.」
Total R&D expenses increased from ¥1 million in the same period of the previous year to ¥16 million. - FY2023Increase in R&D ExpensesAnnual report
「For the current fiscal year, the amount invested in R&D was ¥58 million.」
Total R&D expenses increased from ¥46 million in the previous fiscal year to ¥61.6 million in the current fiscal year. R&D expenses of ¥58 million were recorded in the financial solutions business and ¥3 million in the healthcare business. - FY2023-Q3R&D expenses: ¥26 millionAnnual report
「Total R&D expenses for the first nine months of the current fiscal year were ¥26 million.」
Total R&D expenses of ¥26 million were disclosed. This was down from ¥41 million in the same period of the previous year. - FY2023-Q2Decrease in R&D expensesAnnual report
「Total R&D expenses for the first six months of the current fiscal year were ¥8 million.」
Total R&D expenses decreased from ¥24 million in the same period of the previous year to ¥8 million. - FY2023-Q1Decrease in R&D expensesAnnual report
「Total research and development expenses for the three-month cumulative period of the current consolidated fiscal year were ¥1 million.」
Total R&D expenses decreased from ¥4 million in the same period of the previous year to ¥1 million. - FY2022Increase in R&D ExpensesAnnual report
「For the current fiscal year, the amount invested in R&D was ¥46 million.」
R&D expenses increased from ¥20 million in the previous fiscal year to ¥46 million. The funds were invested in an application for cryptocurrency trading, additional functionality for a derivatives trading system, and research on maitake mushrooms, among other areas. - FY2022-Q3Increase in R&D ExpensesAnnual report
「Total R&D expenses for the first nine months of the current fiscal year were ¥41 million.」
Total R&D expenses were ¥41 million, up from ¥15 million in the same period of the previous year and ¥24 million in the first six months of the current fiscal year. - FY2022-Q2R&D expenses: ¥24 millionAnnual report
「Total R&D expenses for the first six months of the current fiscal year were ¥24 million.」
Total R&D expenses were ¥24 million, up from ¥6 million in the same period of the previous year. - FY2022-Q1R&D expenses: ¥4 millionAnnual report
「R&D expenses for the cumulative period of the current fiscal year through the first quarter totaled ¥4 million.」
Total R&D expenses were ¥4 million, down from ¥12 million in the same period of the previous year. - FY2021Decrease in R&D expensesAnnual report
「For the current fiscal year, the amount invested in R&D was ¥20 million, as the company focused on significantly improving operating profit.」
R&D expenses decreased from ¥29 million in the previous fiscal year to ¥20 million. - FY2021-Q3R&D expenses: ¥15 millionAnnual report
「Total R&D expenses for the third quarter of the current consolidated fiscal year were ¥15 million.」
The total R&D expenses for the first nine months of the current fiscal year were disclosed as ¥15 million. - FY2021-Q2Decrease in R&D expensesAnnual report
「Total research and development expenses for the six-month period of the current fiscal year were ¥6 million.」
Total research and development expenses decreased substantially from ¥167 million in the same period of the previous year to ¥6 million. - FY2021-Q1Research and development expenses: ¥1 millionAnnual report
「Total research and development expenses for the three-month period of the current fiscal year were ¥1 million, down from ¥12 million in the same period of the previous year, because the Financial Solutions Business focused on developing projects for which orders had been received.」
Total research and development expenses decreased from ¥12 million in the same period of the previous year to ¥1 million. The Company explained that the decrease resulted from the Financial Solutions Business focusing on development of projects for which orders had been received. - FY2020R&D expenses: ¥29 millionAnnual report
「For these reasons, we recorded research and development expenses of ¥29 million for the consolidated fiscal year.」
Total research and development expenses decreased from ¥338 million in the previous fiscal year to ¥29 million. - FY2020-Q3Research and development expenses: ¥25 millionAnnual report
「Total research and development expenses for the nine-month period of the current fiscal year were ¥25 million.」
The Company disclosed total research and development expenses of ¥25 million for the nine-month period of the current fiscal year. - FY2020-Q2Decrease in R&D expensesAnnual report
「Total research and development expenses for the six-month period of the current fiscal year were ¥17 million.」
Total research and development expenses were ¥17 million, a substantial decrease from ¥167 million in the same period of the previous year. - FY2020-Q1Research and development expenses: ¥12 millionAnnual report
「Total research and development expenses for the three-month period of the current fiscal year were ¥12 million.」
The Company disclosed total research and development expenses of ¥12 million for the three-month period of the current fiscal year. - FY2019Increase in R&D ExpensesAnnual report
「For these reasons, the Company recorded ¥338 million in research and development expenses during the current fiscal year.」
Total research and development expenses were ¥338 million, a substantial increase from ¥85 million in the previous fiscal year. - FY2019-Q3Increase in R&D ExpensesAnnual report
「Total research and development expenses for the nine-month period of the current fiscal year were ¥272 million.」
Total research and development expenses were ¥272 million, an increase from ¥167 million reported for the previous quarter. - FY2019-Q2First statedAnnual report
「Total research and development expenses for the six-month period of the current fiscal year were ¥167 million.」
Total research and development expenses were ¥167 million, a substantial increase from ¥39 million in the same period of the previous year.